{"article_title": "When It Comes To Its Reputation, The Pharmaceutical Industry Continues To Mess Up", "article_keywords": ["pharmaceutical", "mess", "industry", "continues", "reputation", "comes"], "article_url": "http://www.forbes.com/sites/johnlamattina/2014/09/24/when-it-comes-to-its-reputation-the-pharmaceutical-industry-continues-to-mess-up/", "article_text": "", "article_metadata": {"description": "If these two companies can do this, why can\u2019t all do the same? If two of PhRMA\u2019s biggest players have been doing this for years, why aren\u2019t they all? The Affordable Health Care Act has been in effect for four years. It is not as if the industry didn\u2019t see this coming. Rather than trying to work with CMS, BIO, PhRMA and AdvaMed should have been working with their member companies to mimic the transparency initiatives of Lilly and Pfizer. Such proactive behaviors would have made the Sunshine Act redundant and unnecessary.", "author": "John LaMattina", "og": {"site_name": "Forbes", "description": "If these two companies can do this, why can\u2019t all do the same? If two of PhRMA\u2019s biggest players have been doing this for years, why aren\u2019t they all? The Affordable Health Care Act has been in effect for four years. It is not as if the industry didn\u2019t see this coming. Rather than trying to work with CMS, BIO, PhRMA and AdvaMed should have been working with their member companies to mimic the transparency initiatives of Lilly and Pfizer. Such proactive behaviors would have made the Sunshine Act redundant and unnecessary.", "title": "When It Comes To Its Reputation, The Pharmaceutical Industry Continues To Mess Up", "url": "http://www.forbes.com/sites/johnlamattina/2014/09/24/when-it-comes-to-its-reputation-the-pharmaceutical-industry-continues-to-mess-up/", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "updated_time": "2014-09-24T10:43:07-04:00", "type": "article"}, "twitter": {"description": "If these two companies can do this, why can\u2019t all do the same? If two of PhRMA\u2019s biggest players have been doing this for years, why aren\u2019t they all? The Affordable Health Care Act has been in effect for four years. It is not as if the industry didn\u2019t see this coming. Rather than trying to work with CMS, BIO, PhRMA and AdvaMed should have been working with their member companies to mimic the transparency initiatives of Lilly and Pfizer. Such proactive behaviors would have made the Sunshine Act redundant and unnecessary.", "creator": "@john_lamattina", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "title": "When It Comes To Its Reputation, The Pharmaceutical Industry Continues To Mess Up", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Healthcare Innovation,Pharma and Health,Pharma &amp; Healthcare", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2014-09-24", "published": "2014-09-24", "id": "blogAndPostId/blog/post/2009-1680"}, "news_keywords": "Business,Healthcare Innovation,Pharma and Health,Pharma &amp; Healthcare", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "article_summary": ""}